Okay, let's tackle this question about the mechanism of action of atorvastatin. First, I need to recall what atorvastatin is. It's a statin, right? So statins are used for lowering cholesterol. The core concept here is about lipid-lowering drugs, specifically HMG-CoA reductase inhibitors.

The main mechanism of statins is inhibiting the enzyme HMG-CoA reductase. That enzyme is crucial in the mevalonate pathway for cholesterol synthesis. By blocking this, the liver can't make as much cholesterol, which upregulates LDL receptors, leading to lower LDL levels in the blood.

Looking at the options, the correct answer should be HMG-CoA reductase inhibition. The other options might include things like inhibiting lipoprotein lipase, which is incorrect because that's what some other drugs do. Or maybe inhibiting acetyl-CoA carboxylase, which is involved in fatty acid synthesis, but that's not the target of statins. Another wrong option could be blocking the LDL receptor, which would actually increase LDL levels, so that's opposite of what statins do.

Clinical pearl: Remember that statins work by inhibiting the rate-limiting step in cholesterol synthesis. This is a high-yield fact for exams like NEET and USMLE. Also, side effects like myopathy are due to the inhibition of other isoprenoids, which is part of the mevalonate pathway beyond cholesterol.

**Core Concept**
Atorvastatin is a **HMG-CoA reductase inhibitor**, a class of drugs that lower cholesterol by targeting the rate-limiting enzyme in the mevalonate pathway. This pathway is central to endogenous cholesterol synthesis in the liver.

**Why the Correct Answer is Right**
Atorvastatin irreversibly binds to and inhibits **HMG-CoA reductase**, which catalyzes the conversion of HMG-CoA to mevalonate. By blocking this step, cholesterol synthesis decreases, leading to upregulation of hepatic LDL receptors. This enhances clearance of LDL cholesterol from the bloodstream, reducing cardiovascular risk.

**Why Each Wrong Option is Incorrect**
**Option A:** *Inhibition of lipoprotein lipase* – Incorrect. Lipoprotein lipase is targeted by drugs like fibrates, not statins.
**Option B:** *Inhibition of acetyl-CoA carboxylase* – Incorrect. This enzyme is involved in fatty acid synthesis; its inhibition is a mechanism of action for biguanides (e.g., metformin).
**Option C:** *Blockade of LDL receptor* – Incorrect. Statins upregulate LDL receptors, while this option describes the opposite effect, which would increase LDL levels.

**Clinical Pearl / High-Yield Fact**
Statins reduce LDL cholesterol by inhibiting HMG-CoA reductase. Remember the **"statin suffix"** (e.g., -vastatin) correlates with this mechanism. Side effects like myopathy arise from off-target inhibition of isoprenoid synthesis.

**Correct Answer: C. Inhibition of HMG-CoA reductase**

✓ Correct Answer: D. HMG-CoA reductase inhibitor